Kindling Bio are one of the tenants at the Innovation Gateway and they are pioneering gene therapy solutions for childhood cancers, advancing novel treatments that harness genetic engineering to transform outcomes for young patients.

Populate manages the Innovation Gateway at the London Cancer Hub, providing flexible, fully-serviced laboratory and workspace for early-stage life sciences and health innovators. Located at the heart of the London Cancer Hub in Sutton, the Innovation Gateway supports collaboration between pioneering companies, clinicians and world-leading institutions including The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust.